343 related articles for article (PubMed ID: 32859477)
1. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study.
COVID-19 RISK and Treatments (CORIST) Collaboration
Eur J Intern Med; 2020 Dec; 82():38-47. PubMed ID: 32859477
[TBL] [Abstract][Full Text] [Related]
2. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering.
Di Castelnuovo A; Gialluisi A; Antinori A; Berselli N; Blandi L; Bonaccio M; Bruno R; Cauda R; Costanzo S; Guaraldi G; Menicanti L; Mennuni M; My I; Parruti G; Patti G; Perlini S; Santilli F; Signorelli C; Stefanini G; Vergori A; Ageno W; Agodi A; Agostoni P; Aiello L; Al Moghazi S; Arboretti R; Aucella F; Barbieri G; Barchitta M; Bonfanti P; Cacciatore F; Caiano L; Cannata F; Carrozzi L; Cascio A; Castiglione G; Ciccullo A; Cingolani A; Cipollone F; Colomba C; Colombo C; Crisetti A; Crosta F; Danzi GB; D'Ardes D; de Gaetano Donati K; Di Gennaro F; Di Tano G; D'Offizi G; Fusco FM; Gaudiosi C; Gentile I; Gianfagna F; Giuliano G; Graziani E; Guarnieri G; Langella V; Larizza G; Leone A; Maccagni G; Magni F; Maitan S; Mancarella S; Manuele R; Mapelli M; Maragna R; Marcucci R; Maresca G; Marongiu S; Marotta C; Marra L; Mastroianni F; Mengozzi A; Meschiari M; Milic J; Minutolo F; Mussinelli R; Mussini C; Musso M; Odone A; Olivieri M; Palimodde A; Pasi E; Pesavento R; Petri F; Pivato CA; Poletti V; Ravaglia C; Righetti G; Rognoni A; Rossato M; Rossi I; Rossi M; Sabena A; Salinaro F; Sangiovanni V; Sanrocco C; Schiano Moriello N; Scorzolini L; Sgariglia R; Simeone PG; Spinicci M; Tamburrini E; Torti C; Trecarichi EM; Vettor R; Vianello A; Vinceti M; Virdis A; De Caterina R; Iacoviello L
J Healthc Eng; 2021; 2021():5556207. PubMed ID: 34336157
[TBL] [Abstract][Full Text] [Related]
3. Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.
Catteau L; Dauby N; Montourcy M; Bottieau E; Hautekiet J; Goetghebeur E; van Ierssel S; Duysburgh E; Van Oyen H; Wyndham-Thomas C; Van Beckhoven D;
Int J Antimicrob Agents; 2020 Oct; 56(4):106144. PubMed ID: 32853673
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
5. No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
Sands K; Wenzel R; McLean L; Korwek K; Roach J; Miller K; Poland RE; Burgess LH; Jackson E; Perlin JB
Int J Infect Dis; 2021 Mar; 104():34-40. PubMed ID: 33359949
[TBL] [Abstract][Full Text] [Related]
6. Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study.
Saib A; Amara W; Wang P; Cattan S; Dellal A; Regaieg K; Nahon S; Nallet O; Nguyen LS
PLoS One; 2021; 16(6):e0252388. PubMed ID: 34106964
[TBL] [Abstract][Full Text] [Related]
7. Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.
Guner R; Hasanoglu I; Kayaaslan B; Aypak A; Akinci E; Bodur H; Eser F; Kaya Kalem A; Kucuksahin O; Ates I; Bastug A; Tezer Tekce Y; Bilgic Z; Gursoy FM; Akca HN; Izdes S; Erdem D; Asfuroglu E; Hezer H; Kilic H; Cıvak M; Aydogan S; Buzgan T
J Infect Public Health; 2021 Mar; 14(3):365-370. PubMed ID: 33647553
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine in Hospitalized Patients with COVID-19: Real-World Experience Assessing Mortality.
Annie FH; Sirbu C; Frazier KR; Broce M; Lucas BD
Pharmacotherapy; 2020 Nov; 40(11):1072-1081. PubMed ID: 33044019
[TBL] [Abstract][Full Text] [Related]
9. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study.
Di Castelnuovo A; Costanzo S; Antinori A; Berselli N; Blandi L; Bonaccio M; Cauda R; Guaraldi G; Menicanti L; Mennuni M; Parruti G; Patti G; Santilli F; Signorelli C; Vergori A; Abete P; Ageno W; Agodi A; Agostoni P; Aiello L; Al Moghazi S; Arboretti R; Astuto M; Aucella F; Barbieri G; Bartoloni A; Bonfanti P; Cacciatore F; Caiano L; Carrozzi L; Cascio A; Ciccullo A; Cingolani A; Cipollone F; Colomba C; Colombo C; Crosta F; Danzi GB; D'Ardes D; de Gaetano Donati K; Di Gennaro F; Di Tano G; D'Offizi G; Fantoni M; Fusco FM; Gentile I; Gianfagna F; Grandone E; Graziani E; Grisafi L; Guarnieri G; Larizza G; Leone A; Maccagni G; Madaro F; Maitan S; Mancarella S; Mapelli M; Maragna R; Marcucci R; Maresca G; Marongiu S; Marotta C; Marra L; Mastroianni F; Mazzitelli M; Mengozzi A; Menichetti F; Meschiari M; Milic J; Minutolo F; Molena B; Montineri A; Mussini C; Musso M; Niola D; Odone A; Olivieri M; Palimodde A; Parisi R; Pasi E; Pesavento R; Petri F; Pinchera B; Poletti V; Ravaglia C; Rognoni A; Rossato M; Rossi M; Sangiovanni V; Sanrocco C; Scorzolini L; Sgariglia R; Simeone PG; Taddei E; Torti C; Vettor R; Vianello A; Vinceti M; Virano A; Vocciante L; De Caterina R; Iacoviello L
Thromb Haemost; 2021 Aug; 121(8):1054-1065. PubMed ID: 33412596
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease.
Mallat J; Hamed F; Balkis M; Mohamed MA; Mooty M; Malik A; Nusair A; Bonilla MF
Medicine (Baltimore); 2020 Dec; 99(52):e23720. PubMed ID: 33350752
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
Barratt-Due A; Olsen IC; Nezvalova-Henriksen K; Kåsine T; Lund-Johansen F; Hoel H; Holten AR; Tveita A; Mathiessen A; Haugli M; Eiken R; Kildal AB; Berg Å; Johannessen A; Heggelund L; Dahl TB; Skåra KH; Mielnik P; Le LAK; Thoresen L; Ernst G; Hoff DAL; Skudal H; Kittang BR; Olsen RB; Tholin B; Ystrøm CM; Skei NV; Tran T; Dudman S; Andersen JT; Hannula R; Dalgard O; Finbråten AK; Tonby K; Blomberg B; Aballi S; Fladeby C; Steffensen A; Müller F; Dyrhol-Riise AM; Trøseid M; Aukrust P;
Ann Intern Med; 2021 Sep; 174(9):1261-1269. PubMed ID: 34251903
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans.
Gerlovin H; Posner DC; Ho YL; Rentsch CT; Tate JP; King JT; Kurgansky KE; Danciu I; Costa L; Linares FA; Goethert ID; Jacobson DA; Freiberg MS; Begoli E; Muralidhar S; Ramoni RB; Tourassi G; Gaziano JM; Justice AC; Gagnon DR; Cho K
Am J Epidemiol; 2021 Nov; 190(11):2405-2419. PubMed ID: 34165150
[TBL] [Abstract][Full Text] [Related]
13. Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy.
Spila Alegiani S; Crisafulli S; Giorgi Rossi P; Mancuso P; Salvarani C; Atzeni F; Gini R; Kirchmayer U; Belleudi V; Kurotschka PK; Leoni O; Ludergnani M; Ferroni E; Baracco S; Massari M; Trifirò G;
Rheumatology (Oxford); 2021 Oct; 60(SI):SI25-SI36. PubMed ID: 33856453
[TBL] [Abstract][Full Text] [Related]
14. Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID-19.
Lauriola M; Pani A; Ippoliti G; Mortara A; Milighetti S; Mazen M; Perseghin G; Pastori D; Grosso P; Scaglione F
Clin Transl Sci; 2020 Nov; 13(6):1071-1076. PubMed ID: 32926573
[TBL] [Abstract][Full Text] [Related]
15. EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA.
Delen LA; Gok A; Kasapoglu US; Cagasar O; Gok Z; Berber N; Derya S; Tetik B
Acta Clin Croat; 2022 Nov; 61(3):403-411. PubMed ID: 37492367
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine (HCQ) Treatment for Hospitalized Patients with COVID- 19.
Tsanovska H; Simova I; Genov V; Kundurzhiev T; Krasnaliev J; Kornovski V; Dimitrov N; Vekov T
Infect Disord Drug Targets; 2022; 22(6):e030322201650. PubMed ID: 35240966
[TBL] [Abstract][Full Text] [Related]
18. Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
Kashour Z; Kashour T; Gerberi D; Tleyjeh IM
Clin Transl Sci; 2021 May; 14(3):1101-1112. PubMed ID: 33606894
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study.
Kalligeros M; Shehadeh F; Atalla E; Mylona EK; Aung S; Pandita A; Larkin J; Sanchez M; Touzard-Romo F; Brotherton A; Shah R; Cunha CB; Mylonakis E
J Glob Antimicrob Resist; 2020 Sep; 22():842-844. PubMed ID: 32763357
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.
Özdemir İH; Özlek B; Özen MB; Gündüz R; Çetin N; Bilge AR
Int J Clin Pract; 2021 Feb; 75(2):e13896. PubMed ID: 33280207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
